Psychosis Global Market Report 2025

Description

Psychosis is a mental health condition in which individuals lose touch with reality, experiencing hallucinations, delusions, and disorganized thinking. Rather than being a disorder itself, it is a symptom of various mental illnesses. Early detection enhances treatment outcomes, and effective care through medication, therapy, and support can help individuals regain stability.

The primary types of products for psychosis include tablets, capsules, and injections. Tablets are widely used due to their convenience and precise dosing, ensuring consistent drug levels for effective treatment. The condition encompasses various disease types, including schizophrenia, bipolar disorder, unipolar depression, dementia, and others. These products are distributed through both online and offline channels and are utilized by various end-users, such as hospitals, healthcare clinics, specialty clinics, and others.

The psychosis market research report is one of a series of new reports from The Business Research Company that provides psychosis market statistics, including the psychosis industry global market size, regional shares, competitors with the psychosis market share, detailed psychosis market segments, market trends, and opportunities, and any further data you may need to thrive in the psychosis industry. This psychosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psychosis market size has grown strongly in recent years. It will grow from $9.88 billion in 2024 to $10.49 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising cases of mental health conditions, an increasing demand for mental health therapeutics, the widespread adoption of typical antipsychotics, the expanding use of cognitive behavioral therapy, and the prevalence of stress-inducing global and economic conditions.

The psychosis market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to the increasing prevalence of stress and associated risk factors, the rising mental health burden due to lifestyle changes, expanding government initiatives, the growing adoption of mindfulness-based interventions and therapy programs, and increasing investments in mental health research and innovative treatments. Major trends include the development of novel drug therapies, advancements in diagnostic technologies, the introduction of innovative injectable drugs, the use of biomarkers, and the growing demand for personalized medicines.

The rising incidence of mental health conditions is expected to drive the growth of the psychosis market. Mental health conditions encompass disorders that affect an individual's mood, thinking, behavior, and overall mental well-being. The increase in these conditions is attributed to factors such as heightened stress levels, lifestyle changes, social isolation, economic pressures, and genetic predisposition. Psychosis treatments support patients through early diagnosis, medical intervention, and specialized therapies, leading to greater use of antipsychotic medications and therapeutic options. For example, in 2024, the National Alliance on Mental Illness, a US-based organization, reported that among individuals in the U.S. aged 18-44, psychosis spectrum and mood disorders account for nearly 600,000 hospitalizations annually. As a result, the rising prevalence of mental health conditions is fueling the growth of the psychosis market.

Companies in the psychosis market are focusing on advancing virtual reality (VR) psychological therapy to enhance treatment outcomes through interactive and personalized mental health interventions. VR psychological therapy involves immersing individuals in controlled, computer-generated environments to reduce distress, improve cognitive function, and enhance social skills through guided interventions, offering a safe and effective approach to symptom management. For instance, in April 2022, OxfordVR, a US-based digital therapeutics company, introduced gameChangeVR, a platform designed to guide patients through cognitive behavioral therapy (CBT) in immersive virtual scenarios. The automated VR therapy, delivered over six weekly sessions, demonstrated significant benefits, particularly for individuals facing severe psychological challenges, by reducing paranoia and enhancing overall quality of life. This innovative technology has the potential to expand access to effective mental health care, addressing clinician shortages and providing a scalable solution for millions of patients with severe mental illness.

In March 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired Karuna Therapeutics for $14 billion. This acquisition aims to strengthen Bristol Myers Squibb's neuroscience portfolio by incorporating KarXT, a novel antipsychotic, and expanding its pipeline with potential treatments for schizophrenia, Alzheimer's disease, and other mental health disorders. Karuna Therapeutics is a US-based biopharmaceutical company specializing in the development of psychosis medications.

Major players in the psychosis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Biogen Idec, Dr. Reddy's Laboratories Ltd., Lundbeck A/S, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Neuron Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals S.p.A., Anavex Life Sciences, BioXcel Therapeutics.

North America was the largest region in the psychosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in psychosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the psychosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The psychosis market consists of sales of transdermal patches, nasal sprays, intravenous (IV) infusions, long-acting injectable (LAI) implants, and inhalable formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Psychosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psychosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for psychosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The psychosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product: Tablet; Capsule; Injection
2) By Disease Type: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Disease Types
3) By Distribution Channel: Online; Offline
4) By End-User: Hospitals; Healthcare Clinics; Speciality Clinics; Other End-Users
Subsegments:
1) By Tablet: Antipsychotic Tablets; Mood Stabilizer Tablets
2) By Capsule: Antipsychotic Capsules; Antidepressant Capsules
3) By Injection: Long-acting Injectable Antipsychotics; Short-acting Injectable Antipsychotics
Companies Mentioned:Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34132

1. Executive Summary

2. Psychosis Market Characteristics

3. Psychosis Market Trends And Strategies

4. Psychosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Psychosis Growth Analysis And Strategic Analysis Framework

5.1. Global Psychosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Psychosis Market Growth Rate Analysis
5.4. Global Psychosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Psychosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Psychosis Total Addressable Market (TAM)

6. Psychosis Market Segmentation

6.1. Global Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet
Capsule
Injection
6.2. Global Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Other Disease Types
6.3. Global Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Online
Offline
6.4. Global Psychosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Healthcare Clinics
Speciality Clinics
Other End-Users
6.5. Global Psychosis Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotic Tablets
Mood Stabilizer Tablets
6.6. Global Psychosis Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antipsychotic Capsules
Antidepressant Capsules
6.7. Global Psychosis Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Long-acting Injectable Antipsychotics
Short-acting Injectable Antipsychotics

7. Psychosis Market Regional And Country Analysis

7.1. Global Psychosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Psychosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Psychosis Market

8.1. Asia-Pacific Psychosis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Psychosis Market

9.1. China Psychosis Market Overview
9.2. China Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Psychosis Market

10.1. India Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Psychosis Market

11.1. Japan Psychosis Market Overview
11.2. Japan Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Psychosis Market

12.1. Australia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Psychosis Market

13.1. Indonesia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Psychosis Market

14.1. South Korea Psychosis Market Overview
14.2. South Korea Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Psychosis Market

15.1. Western Europe Psychosis Market Overview
15.2. Western Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Psychosis Market

16.1. UK Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Psychosis Market

17.1. Germany Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Psychosis Market

18.1. France Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Psychosis Market

19.1. Italy Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Psychosis Market

20.1. Spain Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Psychosis Market

21.1. Eastern Europe Psychosis Market Overview
21.2. Eastern Europe Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Psychosis Market

22.1. Russia Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Psychosis Market

23.1. North America Psychosis Market Overview
23.2. North America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Psychosis Market

24.1. USA Psychosis Market Overview
24.2. USA Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Psychosis Market

25.1. Canada Psychosis Market Overview
25.2. Canada Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Psychosis Market

26.1. South America Psychosis Market Overview
26.2. South America Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Psychosis Market

27.1. Brazil Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Psychosis Market

28.1. Middle East Psychosis Market Overview
28.2. Middle East Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Psychosis Market

29.1. Africa Psychosis Market Overview
29.2. Africa Psychosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Psychosis Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Psychosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Psychosis Market Competitive Landscape And Company Profiles

30.1. Psychosis Market Competitive Landscape
30.2. Psychosis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Psychosis Market Other Major And Innovative Companies

31.1. Novartis International AG
31.2. GlaxoSmithKline plc
31.3. Takeda Pharmaceuticals Inc.
31.4. Eli Lilly and Company
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Otsuka Pharmaceutical Co.
31.7. Biogen Idec
31.8. Dr. Reddy's Laboratories Ltd.
31.9. Lundbeck A/S
31.10. Gedeon Richter
31.11. Alkermes
31.12. Supernus Pharmaceuticals
31.13. Acadia Pharmaceuticals
31.14. Neuron Pharmaceuticals
31.15. Mapi Pharma

32. Global Psychosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Psychosis Market

34. Recent Developments In The Psychosis Market

35. Psychosis Market High Potential Countries, Segments and Strategies

35.1 Psychosis Market In 2029 - Countries Offering Most New Opportunities
35.2 Psychosis Market In 2029 - Segments Offering Most New Opportunities
35.3 Psychosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer